Coldstream Capital Management Inc Biogen Inc. Transaction History

Coldstream Capital Management Inc

$4.58 Billion
Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,397 shares of BIIB stock, worth $361,084. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,397

Previous 2,697 11.12%

Holding current value

$361,084

Previous $625,000 25.76%

% of portfolio

0.01%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$189.07 - $236.8 $56,721 - $71,040	-300 Reduced 11.12%	2,397 $464,000
Q2 2024 Aug 07, 2024	BUY	$190.52 - $236.72 $82,876 - $102,973	435 Added 19.23%	2,697 $625,000
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $4,240 - $5,354	-20 Reduced 0.88%	2,262 $487,000
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $74,122 - $89,224	333 Added 17.09%	2,282 $590,000
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $61,045 - $68,899	-241 Reduced 11.0%	1,949 $500,000
Q2 2023 Aug 03, 2023	BUY	$275.25 - $318.06 $11,010 - $12,722	40 Added 1.86%	2,190 $623,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $5,131 - $5,846	-20 Reduced 0.92%	2,150 $597,000
Q4 2022 Jan 10, 2023	BUY	$252.44 - $306.72 $42,409 - $51,528	168 Added 8.39%	2,170 $0
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $101,459 - $120,653	541 Added 37.03%	2,002 $408,000
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $48,385 - $57,539	258 Added 21.45%	1,461 $298,000
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $52,124 - $65,673	-269 Reduced 18.27%	1,203 $253,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $84,641 - $108,777	378 Added 34.55%	1,472 $353,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $21,507 - $28,047	-76 Reduced 6.5%	1,094 $310,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $73,815 - $118,192	285 Added 32.2%	1,170 $405,000
Q1 2021 Jun 16, 2021	SELL	$242.95 - $284.63 $48,347 - $56,641	-199 Reduced 18.36%	885 $248,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $256,105 - $385,502	1,084 New	1,084 $265,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $204,402 - $236,008	-772 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $11,381 - $15,072	-44 Reduced 5.39%	772 $207,000
Q1 2020 May 27, 2020	SELL	$268.85 - $341.04 $47,586 - $60,364	-177 Reduced 17.82%	816 $258,000
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $21,785 - $30,102	99 Added 11.07%	993 $294,000
Q3 2019 Nov 15, 2019	BUY	$217.44 - $243.88 $194,391 - $218,028	894 New	894 $208,000
Q4 2018 Feb 26, 2019	SELL	$278.5 - $352.75 $206,647 - $261,740	-742 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $217,784 - $284,801	742 New	742 $262,000
Q1 2018 May 16, 2018	SELL	$260.13 - $367.91 $256,748 - $363,127	-987 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $69,219 - $77,530	225 Added 29.53%	987 $314,000
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $214,236 - $251,223	762	762 $239,000

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Biogen Inc. Transaction History